Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 65Neoplasms 56Prostatic Neoplasms 44Lung Neoplasms 35Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 24Pancreatic Neoplasms 21Hematologic Neoplasms 19Head and Neck Neoplasms 16Neoplasm Metastasis 15Urinary Bladder Neoplasms 12Ovarian Neoplasms 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Motor Activity 10Triple Negative Breast Neoplasms 9Multiple Myeloma 9Colonic Neoplasms 9Melanoma 8Glioma 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Glioblastoma 7Gastrointestinal Neoplasms 7Esophageal Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Smoking Cessation 6Sarcoma 6Rectal Neoplasms 6

Interventions

olaparib 1decitabine and cedazuridine drug combination 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × BRCA1 Mutation × Standard of Care × Clear all
NCT05420064 2025-11-12

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
1,000 enrolled

BRCA1 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡